All News

Transplant drug added to PREDICT program

Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection.

Stem Cell Transplant Survivors Reunion

VUMC’s Hoy lands transplant provider award

Haley Hoy, Ph.D., ACNP, recently received the 2013 Advanced Transplant Provider Award from the American Society of Transplant Surgeons (ASTS) during its Winter Symposium.

Kidney Transplantation Program celebrates 50 years

There are many reasons why David Shaffer, M.D., surgical director of the Kidney Transplantation Program at Vanderbilt University Medical Center, loves his job.

Transplant surgery

Transplant Center programs honored for strong outcomes

Three Vanderbilt Transplant Center programs were recently recognized for having high-performing outcomes by the Donation and Transplantation Community of Practice of the Health Resources and Services Administration.

Targeting post-transplant diabetes

Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.

1 62 63 64 65 66 70